“Rationale for the Design of Combination Therapies That Are Active in T-Cell Lymphomas?”. Hematology Meeting Reports 2, no. 13 (June 10, 2009). Accessed May 28, 2026. https://journals.pagepress.net/hmr/article/view/498.